THE Royal College of Physicians of Edinburgh has launched a new report on drug-related deaths in Scotland, based on the views of leading experts.

The report recognises that Scotland’s drug deaths crisis is complex, but says much more can be done to tackle the problem, including action on harm reduction and on the social determinants of drug abuse.

The college believes that bold policies, such as decriminalisation of the possession of drugs, safe drug consumption facilities, and rolling out a heroin assisted treatment programme in all major centres in Scotland should be considered to help reduce drug-related harms.

Urgent research is required to examine the links between poverty and drug-related deaths, including the impact of Covid-19 on drug use. There is also an urgent requirement to study and understand complex multi-drug use, as the National Records of Scotland (NRS) data for 2019 show that the number of drug-related deaths of people who took more than one substance was 94%.

READ MORE: Activist opens pop-up drug tent allowing addicts to inject safely in Glasgow

The college is also calling for more joined up care for people who use drugs, as well as support for those who have completed rehab or who have left hospital after being admitted for drug overdose.

The report makes five key recommendations to help reduce drug-related deaths in Scotland:

  • Decriminalisation: the Scottish Government and the UK Government must give evidence-based consideration to the decriminalisation of drug use.
  • Constructive political debate: the college calls on politicians to work constructively together on drug-related deaths, and to listen carefully to the views of front-line clinicians and researchers.
  • Cross-party consensus: continued and increasing cross-party and cross-discipline engagement is required to effectively manage drug-related deaths and deliver real and measurable change.
  • Socio-economic factors: the UK Government and Scottish Government must work together to address the socio-economic factors associated with drug use such as employment and income, social security, education, public health, support services and housing – as well as the physical and psychological factors.
  • The medical community: leaders of the medical professions must support educational initiatives which maximise the involvement of all sectors of medicine in managing problems related to drug and alcohol dependency.
  • Drug-related deaths is a complex issue caused by a wide range of factors including high levels of deprivation in the most affected communities, an ageing population of people who use or have used drugs in the past, psychological trauma, high-risk patterns of drug use, the risky behaviours of some people who use drugs and stigma by society.

In December last year, the NRS reported that the number of drug-related deaths recorded in Scotland was 1264 during 2019, a rise of 6% on 2018, when 1187 drug related deaths were recorded. The number of drug-related deaths in Scotland is now the highest since records began in 1996.

Subsequently, a new minister for drugs policy – Angela Constance MSP – was appointed. The college supports Constance’s move to roll out naloxone kits to help save lives of people who use drugs.

The college is calling on Constance to maintain an “open dialogue” with the wider medical community on policies which could give people who use drugs person-centred care.

READ MORE: Project aiming to save lives of drug addicts with family bonds set to begin

Finally, the college will use its own position as a medical educator to inform healthcare workers across Scotland and the UK about drug-related deaths, and intends to host some online courses in future.

Professor Angela Thomas, acting president of the college, said: “Our report follows the revelation by the NRS that the number of drug-related deaths in Scotland grew 6% during 2019. Each death represents the life of someone who had friends, family and support networks who cared deeply about them, which is absolutely heart-breaking. Our aim is to support the good work of the Drug Deaths Taskforce, put forward helpful suggestions based on our clinical expertise, encourage debate, and support medical education on this critical issue.”